ABOUT LYSSA

Lyssa Friedman is a clinical operations executive with clinical study expertise in pharma, diagnostics and health services research across indications. Lyssa’s ability to solve complex challenges and develop and manage collaborative teams has resulted in the successful achievement of critical milestones. She executed a 50-center, 4000-patient study with airtight data that led to early product launch, rapid market share, high-impact peer-reviewed publications and positive payer decisions.

Lyssa is recognized for her ability to build relationships. Her track record of gaining the trust and confidence of thought leaders and collaborators has helped drive acceptance of abstracts and manuscripts and development of key customers.

Lyssa has directed all phases of clinical operations from single- to multi-center studies, and she has deep expertise in phase II-IV studies, sample collection studies for diagnostics development, health economics, clinical utility and clinical outcomes studies.

As a senior leader, Lyssa manages operations across functional areas, and she develops strategic product lifecycle, commercial and reimbursement plans.